DrugBank 5.0: a major update to the DrugBank database for 2018
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
DrugBank (www.drugbank.ca) is a web-enabled database containing comprehensive molecular information about drugs, their mechanisms, their interactions and their targets. First described in 2006, DrugBank has continued to evolve over the past 12 years in response to marked improvements to web standards and changing needs for drug research and development. This year's update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years. In many cases, existing data content has grown by 100% or more over the last update. For instance, the total number of investigational drugs in the database has grown by almost 300%, the number of drug-drug interactions has grown by nearly 600% and the number of SNP-associated drug effects has grown more than 3000%. Significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions. A great deal of brand new data have also been added to DrugBank 5.0. This includes information on the influence of hundreds of drugs on metabolite levels (pharmacometabolomics), gene expression levels (pharmacotranscriptomics) and protein expression levels (pharmacoprotoemics). New data have also been added on the status of hundreds of new drug clinical trials and existing drug repurposing trials. Many other important improvements in the content, interface and performance of the DrugBank website have been made and these should greatly enhance its ease of use, utility and potential applications in many areas of pharmacological research, pharmaceutical science and drug education.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DrugBank primarily contains drug indications extracted from drug labels, while MEDI utilizes public internet sources to drug indications, and is a well utilized resource of drug indications.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, we searched DrugBank84 to identify therapeutic compounds targeting AD-associated proteins. Of the 38 proteins, 15 had reported molecules (Fig. 4D).”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [84]
In the citing paper
“AVPR2 and NPR1 genes play pivotal roles in regulating fluid and electrolyte balance via complementary but distinct pathways. AVPR2 contributes to water retention and urine concentration, whereas NPR1 facilitates vasodilatation, lowers blood pressure and enhances water excretion47.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [47]
In the citing paper
“In essence, the CC is an alternative representation of the small-molecule knowledge deposited in the public domain and, as such, it is also limited by the availability of experimental data and the coverage of its source databases (e.g., ChEMBL9 or DrugBank10).”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892 · cited 1×
“DrugBank 1.0, released in 2006, provided novel (at the time) physico-chemical data on selected FDA-approved drugs and their drug-targets (2).”
BackgroundInfluentialSelf-citationDrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861 · cited 1×
“DrugBank 2.0, released in 2008, added pharmacological, pharmacogenomic and molecular biological data (3).”
BackgroundInfluentialSelf-citationThe new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161 · cited 2×
“org and FDA labels), as well as material collated from sources such as The Human Cytochrome P450 (CYP) Allele Nomenclature Database (12) and the NHGRI-EBI GWAS Catalog (13).”
BackgroundDrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993 · cited 1×
“tion, distribution, metabolism, excretion and toxicity) data (5).”
Self-citationDrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831 · cited 1×
“DrugBank 3.0, released in 2010, added drug–drug and drug–food interactions, drug transporter data as well as pharmacokinetic information (4).”
BackgroundInfluentialSelf-citationClassyFire: automated chemical classification with a comprehensive, computable taxonomy
Djoumbou Feunang, Y., Eisner, R., Knox, C., Chepelev, L., Hastings, J., Owen, G., Fahy, E., Steinbeck, C., Subramanian, S., Bolton, E., et al. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0174-y · Cited by 1,525
Self-citationThe Comparative Toxicogenomics Database: update 2017
Davis, A. P., Grondin, C. J., Johnson, R. J., Sciaky, D., King, B. L., McMorran, R., Wiegers, J., Wiegers, T. C., & Mattingly, C. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw838 · Cited by 544 · cited 1×
“Additional pharmacoproteomic and pharmacotranscriptomic data were obtained from the CTD (18).”
MethodPredicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502 · cited 1×
“It has also become much more robust and sophisticated (21).”
BackgroundAllen, F., Pon, A., Wilson, M., Greiner, R., & Wishart, D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku436 · Cited by 464 · cited 7×
“In particular, CFM-ID (19) and CFM-ID 2.”
BackgroundInfluentialSelf-citationSim, S. C., & Ingelman-Sundberg, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-4-278 · Cited by 216 · cited 2×
“org and FDA labels), as well as material collated from sources such as The Human Cytochrome P450 (CYP) Allele Nomenclature Database (12) and the NHGRI-EBI GWAS Catalog (13).”
Background
Cited by
Items 701–800 of 1,056
Machine Learning Uncovers Food- and Excipient-Drug Interactions
Reker, D., Shi, Y., Kirtane, A. R., Hess, K., Zhong, G. J., Crane, E., Lin, C.-H., Langer, R., & Traverso, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.094 · Cited by 63
“Interestingly, both IIG and GRAS compounds resemble approved drugs (DrugBank 5.0; Wishart et al., 2018), according to many important molecular properties (Table S2), most notably (Figure 1B) the fraction of rotatable bonds, the molecular weight, and the predicted logP (cLogP).”
InfluentialPathogenetic profiling of COVID-19 and SARS-like viruses
Nain, Z., Rana, H. K., Lió, P., Islam, S. M. S., Summers, M. A., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa173 · Cited by 68
“0 and Comparative Toxicogenomics Database, respectively [42, 43].”
An Open Access Database of Licensed Cancer Drugs
Pantziarka, P., Capistrano, R., Potter, A. D., Vandeborne, L., & Bouche, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.627574 · Cited by 70
“Data on themedical uses for drugs is derived from theDrugBank database (Wishart et al., 2018).”
MethodBess, A., Berglind, F., Mukhopadhyay, S., Bryliński, M., Griggs, N. W., Cho, T., Galliano, C., & Wasan, K. M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.022 · Cited by 70
Recombinant vaccines in 2022: a perspective from the cell factory
Favaro, M. T. D. P., Atienza-Garriga, J., Martínez-Torró, C., Parladé, E., Vázquez, E., Corchero, J. L., Ferrer‐Miralles, N., & Villaverde, A. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01929-8 · Cited by 68
“Therefore, the trend in immunization is shifting towards the exploration of this technology, as demonstrated by the significant number of approved recombinant vaccines (Table 1, [74, 75]).”
BackgroundIntegrated proteogenomic characterization of medullary thyroid carcinoma
Xiao Hua, S. H. I., Sun, Y., Shen, C., Zhang, Y., Shi, R., Zhang, F., Liao, T., Lv, G., Zhu, Z., Jiao, L., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00479-y · Cited by 70
Plant glycosyltransferases for expanding bioactive glycoside diversity
Sirirungruang, S., Barnum, C. R., Tang, S. N., & Shih, P. M. (2023) · Natural Product Reports · doi:10.1039/d2np00077f · Cited by 65
MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction
Han, C., Wang, C.-C., Huang, L., & Chen, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad215 · Cited by 68
Wang, T., Wang, R., & Wei, L. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00709 · Cited by 68
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential
Raman, A. P. S., Aslam, M., Awasthi, A., Ansari, A., Jain, P., Lal, K., Bahadur, I., Singh, P. K., & Kumari, K. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10858-0 · Cited by 71
ClinicalAgent: Clinical Trial Multi-Agent System with Large Language Model-based Reasoning
Yue, L., Xing, S., Chen, J., & Fu, T. (2024) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3698587.3701359 · Cited by 113
“This agent utilizes advanced data retrieval and analysis techniques, drawing from rich biomedical databases such as DrugBank [31] and the HetioNet Knowledge Graph to ensure comprehensive and accurate evaluations.”
BackgroundMethodInfluentialYang, L., Wang, H., Zhu, Z., Yang, Y. G., Xiong, Y., Cui, X., & Liu, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18071074 · Cited by 76
Self-citationJang, H. Y., Song, J., Kim, J. H., Lee, H., Kim, I.-W., Moon, B., & Oh, J. M. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00639-0 · Cited by 63
Ji, X., Tong, W., Liu, Z., & Shi, T. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00600 · Cited by 69
“SMILES information was obtained from DrugBank.”
MethodInfluentialDrug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
Senćanski, M., Perović, V., Pajović, S. B., Adžić, M., Paessler, S., & Glišić, S. (2020) · Molecules · doi:10.3390/molecules25173830 · Cited by 63
“First, the Informational spectrum method applied for Small Molecules (ISM-SM) was used for searching Drugbank database [12], and further was followed by molecular docking.”
MethodInfluentialMulti-omics study for interpretation of genome-wide association study
Akiyama, M. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-00842-5 · Cited by 68
“Second, various biological resources such as genetic associations with other traits (pleiotropy) [53], microbiomes [54], transcription factor chromatin immunoprecipitation data [55], mouse knockout phenotypes [56], and drug databases [57, 58] are now available.”
BackgroundShitrit, A., Zaidman, D., Kalid, O., Bloch, I., Doron, D., Yarnizky, T., Buch, I., Segev, I., Ben‐Zeev, E., Segev, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77794-5 · Cited by 66
The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Chiou, W.-C., Chen, J., Chen, Y., Yang, J., Hwang, L., Lyu, Y.-S., Yang, H.-Y., & Huang, C. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.106 · Cited by 63
Rufer, A. C. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.006 · Cited by 67
A network embedding framework based on integrating multiplex network for drug combination prediction
Yu, L., Xia, M., & An, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab364 · Cited by 69
Zhang, X., Wang, G., Meng, X., Wang, S., Zhang, Y., Rodríguez‐Patón, A., Wang, J., & Wang, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac296 · Cited by 64
Pandiyan, S., & Wang, L. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106140 · Cited by 70
A landscape of response to drug combinations in non-small cell lung cancer
Nair, N. U., Greninger, P., Zhang, X., Friedman, A. A., Amzallag, A., Cortez, E., Sahu, A. D., Lee, J. S., Dastur, A., Egan, R. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39528-9 · Cited by 73
Can large language models understand molecules?
Sadeghi, S., Bui, A., Forooghi, A., Lu, J., & Ngom, A. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05847-x · Cited by 81
“For the link prediction task, however, we utilize two DDI networks: BioSnap [37] and DrugBank [38].”
Wang, X., Wang, Y., Yuan, T., Wang, H., Zeng, Z., Tian, L., Cui, L., Guo, J., & Chen, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156062 · Cited by 74
Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin
Yan, J., Liu, H., Yang, W., Liu, N., Wang, J., Li, Z., Liu, T., Yan, S., & He, W. (2025) · Nature Communications · doi:10.1038/s41467-025-61112-6 · Cited by 70
Weston, M., Kaserer, T., Wu, A. J., Mouravlev, A., Carpenter, J. C., Snowball, A., Knauß, S., von Schimmelmann, M. J., During, M. J., Lignani, G., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw1567 · Cited by 68
Lessons from Exploring Chemical Space and Chemical Diversity of Propolis Components
Tran, T. D., Ogbourne, S. M., Brooks, P. R., Sánchez‐Cruz, N., Medina‐Franco, J. L., & Quinn, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144988 · Cited by 66
“…including a large collection of food chemicals (FC) (http: // foodb.ca / ) and FDA-approved small molecule drugs obtained from Drugbank (DB) [227] (https: // www.drugbank. of pharmaceuticals nutraceuticals based on the chemical structure perspective, the HBP and SBP molecular were compared…”
Computational Drug Repositioning: Current Progress and Challenges
Ko, Y. (2020) · Applied Sciences · doi:10.3390/app10155076 · Cited by 67
“accumulate within various databases, such as DrugBank [10], ChemBank [11], Genecard [12], OMIM [13], and PubMed (Table 2).”
BackgroundGupta, P. S. S., Biswal, S., Panda, S. K., Ray, A. K., & Rana, M. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1839564 · Cited by 70
“Downloaded from Drug Bank (Wishart et al., 2018), the SMILES of Ivermectin was converted to the 3D coordinates using Open Babel (O’Boyle et al., 2011), and next geometry optimization using Gaussian 16 at the level DFT/B3LYP/6-31þG (d, p).”
MethodVirtualTaste: a web server for the prediction of organoleptic properties of chemical compounds
Fritz, F., Preißner, R., & Banerjee, P. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab292 · Cited by 69
“A total of 1969 compounds were collected from the DrugBank database (16) and were predicted using the VirtualTaste models.”
MethodChu, X., Jaeger, M., Beumer, J., Bakker, O. B., Aguirre‐Gamboa, R., Oosting, M., Smeekens, S. P., Moorlag, S. J. C. F. M., Mourits, V. P., Koeken, V. A. C. M., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02413-z · Cited by 66
“Table S14 Additional file 16.”
BackgroundExpanding biochemical knowledge and illuminating metabolic dark matter with ATLASx
MohammadiPeyhani, H., Hafner, J., Sveshnikova, A. N., Viterbo, V., & Hatzimanikatis, V. (2022) · Nature Communications · doi:10.1038/s41467-022-29238-z · Cited by 64
Chen, Q., Lee, K., Yan, S., Kim, S., Wei, C.-H., & Lu, Z. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007617 · Cited by 62
Regan, K., Xu, J., DiVincenzo, M. J., Duggan, M. C., Shakya, R., Na, R., Carson, W. E., Payne, P., & Li, F. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0085-4 · Cited by 68
Spakowicz, D., Hoyd, R., Muniak, M., Husain, M., Bassett, J. S., Wang, L., Tinoco, G., Patel, S. H., Burkart, J., Miah, A., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06882-6 · Cited by 62
Palmeira, A., Sousa, E., Köseler, A., Sabırlı, R., Gören, T., Türkçüer, İ., Kurt, Ö., Pinto, M. M. M., & Vasconcelos, M. H. (2020) · Pharmaceuticals · doi:10.3390/ph13060132 · Cited by 62
“The DrugBank database is a comprehensive, freely accessible, online database containing information on drugs and drug targets [30], which can be a valuable source for the search of known drugs/bioactive compounds with off-target anti-Covid-19 activity.”
BackgroundUnni, S., Aouti, S., Thiyagarajan, S., & Padmanabhan, B. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00102-w · Cited by 63
“In silico screening, docking, and molecular dynamics simulation studies were performed to identify repurposing drugs using DrugBank and PubChem library against the RBD of S-protein.”
InfluentialBello, M., Muñoz, A. M., & Balbuena-Rebolledo, I. (2020) · Journal of Molecular Modeling · doi:10.1007/s00894-020-04600-4 · Cited by 62
Random forest classification for predicting lifespan-extending chemical compounds
Kapsiani, S., & Howlin, B. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-93070-6 · Cited by 71
Lowe, C. N., & Williams, A. J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01273 · Cited by 62
In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer
Rasul, H. O., Aziz, B. K., Ghafoor, D. D., & Kıvrak, A. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-05010-w · Cited by 72
Drug-likeness scoring based on unsupervised learning
Lee, K.-H., Jang, J., Seo, S., Lim, J., & Kim, W. Y. (2022) · Chemical Science · doi:10.1039/d1sc05248a · Cited by 74
Ren, Z.-H., Yu, C.-Q., Li, L., You, Z., Guan, Y.-J., Wang, X., & Pan, J. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac004 · Cited by 69
Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19
Li, F., Boon, A. C. M., Michelson, A. P., Foraker, R. E., Zhan, M., & Payne, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-13585-4 · Cited by 68
Systems pharmacology approaches in herbal medicine research: a brief review
Lee, M., Shin, H., Park, M., Kim, A., Cha, S., & Lee, H. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.9.102 · Cited by 76
“, 2012 (47) Herb-target interactions Ligand-target interaction prediction (30) TCMSP (22), DrugBank (64), PharmGKB (65), TTD (29)”
BackgroundInfluentialProteogenomic characterization of MiT family translocation renal cell carcinoma
Qu, Y., Wu, X., Anwaier, A., Feng, J., Xu, W., Pei, X., Zhu, Y., Liu, Y., Bai, L., Yang, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34460-w · Cited by 64
Self-citationKang, J., Yang, L., Jia, T., Zhang, W., Wang, L., Zhao, Y., You, J., Deng, Y., Ge, Y., Liu, W., et al. (2024) · Science Bulletin · doi:10.1016/j.scib.2024.09.041 · Cited by 73
Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses
Islam, T., Rahman, M. R., Göv, E., Turanlı, B., Gülfidan, G., Haque, A., Arğa, K. Y., & Mollah, N. H. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0048 · Cited by 68
“Drugdescrip-tionsaretakenfromDrugBankdatabase(Wishartetal.,2018).”
Chelating principles in Menkes and Wilson diseases
Horn, N., Møller, L. B., Nurchi, V. M., & Aaseth, J. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.10.009 · Cited by 68
Zheng, Y., Peng, H., Zhang, X., Zhao, Z., Gao, X., & Li, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3214-6 · Cited by 79
“Train a SVM classifier S using P and RNSs ; Let the samples in RU classified as negatives be V ; side-effects and indications are 1,620 unique side-effects in SIDER [28], and 610 unique indications in DrugBank [26] respectively.”
BackgroundMethodDrug-pathway association prediction: from experimental results to computational models
Wang, C.-C., Zhao, Y., & Chen, X. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa061 · Cited by 66
Xuan, P., Gao, L., Sheng, N., Zhang, T., & Nakaguchi, T. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3039502 · Cited by 62
Potentially highly potent drugs for 2019-nCoVPreprint
Nguyen, D. D., Gao, K., Chen, J., Wang, R., & Wei, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.05.936013 · Cited by 64
Madden, J. C., Pawar, G. V., Cronin, M., Webb, S. D., Tan, Y., & Paini, A. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.03.001 · Cited by 67
“ca/ [58] Key ADME properties for drugs e.”
BackgroundSigalova, O. M., Shaeiri, A., Forneris, M., Furlong, E. E. M., & Zaugg, J. B. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209539 · Cited by 64
Ghovanloo, M., Choudhury, K., Bandaru, T. S., Fouda, M. A., Rayani, K., Rusinova, R., Phaterpekar, T., Nelkenbrecher, K., Watkins, A. R., Poburko, D., et al. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012701 · Cited by 67
SANCDB: an update on South African natural compounds and their readily available analogs
Diallo, B. N., Glenister, M., Musyoka, T. M., Lobb, K. A., & Bishop, Ö. T. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00514-2 · Cited by 67
“Compound IDs for different databases (ChEMBL [31], DrugBank [32], ZINC [33], PubChem [34]) were automatically retrieved from PubChem [34].”
MethodInfluentialNiu, B., Xie, X., Xiong, X.-M., & Jiang, J. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104636 · Cited by 69
Qureshi, R., Zou, B., Alam, T., Wu, J., Lee, V. H. F., & Yan, H. (2023) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3141697 · Cited by 60
“In addition, online freely drugdatabases, such as drug-bank [167] can be exploited for”
BackgroundMultimodal reasoning based on knowledge graph embedding for specific diseases
Zhu, C., Yang, Z., Xia, X., Li, N., Zhong, F., & Liu, L. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac085 · Cited by 67
Feng, Y.-H., & Zhang, S. (2022) · Molecules · doi:10.3390/molecules27093004 · Cited by 62
“In order to compare those features with other molecular structure fingerprint features and features from their biological properties, we also extracted the ATC (Anatomical Therapeutic Chemical Classification) and DBP (Drug Binding Proteins) from DrugBank, and utilized the PubChem fingerprint and the MACCSkeys fingerpr…”
MethodNanotechnology as a tool to overcome macromolecules delivery issues
Tundisi, L. L., Ataide, J. A., Costa, J. S. R., Coêlho, D. D. F., Liszbinski, R. B., Lopes, A. M., Nascimento, L. D. O., de Jesus, M. B., Jozala, Â. F., Ehrhardt, C., et al. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113043 · Cited by 64
Tang, Z., Chen, G., Yang, H., Zhong, W., & Chen, C. Y. (2023) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2023.3242656 · Cited by 72
“We evaluate DSIL-DDI on Drugbank [15] and Twosides [3].”
MethodWinsvold, B. S., Harder, A. V. E., Ran, C., Chalmer, M. A., Dalmasso, M. C., Ferkingstad, E., Tripathi, K. P., Bacchelli, E., Børte, S., Fourier, C., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26743 · Cited by 66
Mangoni, A. A., & Jarmuzewska, E. A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13760 · Cited by 65
Guo, Z.-H., You, Z., Huang, D.-S., Yi, H.-C., Zheng, K., Chen, Z., & Wang, Y. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa037 · Cited by 69
“A total of 28 211 known drug-target interactions were downloaded from DrugBank in 8 May 2019 [23].”
BackgroundPotential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2
Pokhrel, R., Chapagain, P. P., & Siltberg-Liberles, J. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001203 · Cited by 63
“The fifth candidate, rifampin, is a broad-spectrum antibiotic that is often used to treat mycobacterial infections such as tuberculosis [37].”
Al-Mustanjid, M., Mahmud, S., Royel, M. R. I., Rahman, M. H., Islam, T., Rahman, M. R., & Moni, M. A. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.001 · Cited by 74
Romeo, A., Iacovelli, F., & Falconi, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198068 · Cited by 61
Bioinformatics: new tools and applications in life science and personalized medicine
Branco, I., & Choupina, A. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11056-2 · Cited by 70
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth
Niu, M., Xu, J., Liu, Y., Li, Y., He, T., Ding, L., He, Y., Yi, Y., Li, F., Guo, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26222-x · Cited by 59
Self-citationIwata, H., Matsuo, T., Mamada, H., Motomura, T., Matsushita, M., Fujiwara, T., Maeda, K., & Handa, K. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00318 · Cited by 65
Roshanzamir, F., Robinson, J. L., Cook, D., Karimi‐Jafari, M. H., & Nielsen, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205456119 · Cited by 62
Auto3D: Automatic Generation of the Low-Energy 3D Structures with ANI Neural Network Potentials
Liu, Z., Zubatiuk, T. A., Roitberg, A. E., & Isayev, O. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00817 · Cited by 73
Diastereoselective Synthesis of Cyclopropanes from Carbon Pronucleophiles and Alkenes
Kim, M. J., Wang, D. J., Targos, K., Garcia, U. A., Harris, A. F., Guzei, I. A., & Wickens, Z. K. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202303032 · Cited by 60
Bhattacharya, S., Mahato, R. K., Singh, S., Bhatti, G. K., Mastana, S. S., & Bhatti, J. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122110 · Cited by 69
Zhang, L., Wang, C.-C., Zhang, Y., & Chen, X. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107512 · Cited by 63
Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
Alaimo, S., & Pulvirenti, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_6 · Cited by 67
Costa-Dookhan, K. A., Agarwal, S. M., Chintoh, A. F., Tran, V., Stogios, N., Ebdrup, B. H., Sockalingam, S., Rajji, T. K., Remington, G. J., Siskind, D. J., et al. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1698545 · Cited by 64
When Does the IC50 Accurately Assess the Blocking Potency of a Drug?
Gomis-Tena, J., Brown, B. M., Cano, J., Trénor, B., Yang, P., Sáiz, J., Clancy, C. E., & Romero, L. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01085 · Cited by 64
Yuan, N., Gong, L., Tang, K., He, L., Hao, W., Li, X., Ma, Q., & Chen, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00284 · Cited by 60
“…2 March 2020 | Volume 11 | Article 284 Known antidepressant drug/drug-like compounds from DrugBank database DrugBank (http://www.drugbank.ca/) is a unique online database used as a bioinformatics and cheminformatics resource that compiles extensive drug-related information (Wishart et al., 2017).”
BackgroundHe, K., Borthwick, A. G. L., Lin, Y., Li, Y., Fu, J., Wong, Y. J., & Liu, W. (2020) · Environment International · doi:10.1016/j.envint.2020.105690 · Cited by 62
Sun, C. Y., Xuan, P., Zhang, T., & Ye, Y. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2999084 · Cited by 65
Few-shot link prediction via graph neural networks for Covid-19 drug-repurposingPreprint
Ioannidis, V. N., Zheng, D., & Karypis, G. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.10261 · Cited by 71
“The DRKG collects interactions from a collection of biological databases such as Drugbank (DS et al., 2017b), GNBR (Percha & Altman, 2018), Hetionet (DS et al., 2017a), STRING (D et al., 2019), IntAct (Orchard et al., 2014) and DGIdb (Cotto et al., 2017).”
MethodFernández-Torras, A., Duran-Frigola, M., Bertoni, M., Locatelli, M., & Aloy, P. (2022) · Nature Communications · doi:10.1038/s41467-022-33026-0 · Cited by 59
The emerging role of computational design in peptide macrocycle drug discovery
Mulligan, V. K. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1751117 · Cited by 58
“The majority of pharmaceuticals in use today are small molecules: of 3,967 approved drugs indexed in DrugBank [26,27], just over half (2,014 drugs) are molecules obeying the Lipinski criterion of being under 500 Da in mass [28].”
BackgroundPeng, Y., Yuan, M., Xin, J., Liu, X., & Wang, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa563 · Cited by 64
FusionGDB 2.0: fusion gene annotation updates aided by deep learning
Kim, P., Tan, H., Liu, J., Lee, H., Jung, H., Kumar, H., & Zhou, X. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1056 · Cited by 61
“8) with the duplicated DTI pairs excluded (29).”
Joshi, P., Masilamani, V., & Mukherjee, A. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104122 · Cited by 66
Gammal, R. N. E., Elmansi, H., El-Emam, A. A.-R., Belal, F. F., & Hammouda, M. E. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15696-4 · Cited by 59
Deep learning large-scale drug discovery and repurposing
Yu, M., Li, W., Yu, Y., Zhao, Y., Xiao, L., Lauschke, V. M., Cheng, Y.-Y., Zhang, X., & Wáng, Y. (2024) · Nature Computational Science · doi:10.1038/s43588-024-00679-4 · Cited by 69
“To avoid the situation of label conflict, we referenced three databases: the Drug Repurposing Hub 51 , ChEMBL 52 and Drugbank 53 , and prioritized consensus annotations found across all three sources.”
Li, V. O. K., Yang, H., Kaistha, T., Zhang, Q., Downey, J. S., Gozes, I., & Lam, J. C. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-85947-7 · Cited by 70
Munz, N., Fu, Q., Stamm, C., & Hollender, J. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b03632 · Cited by 62
Gómez‐Canela, C., Pueyo, V., Barata, C., Lacorte, S., & Marcé, R. M. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.02.078 · Cited by 59
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data
Pulley, J. M., Rhoads, J. P., Jerome, R. N., Challa, A. P., Erreger, K., Joly, M. M., Lavieri, R. R., Perry, K. E., Zaleski, N. M., Shirey-Rice, J. K., et al. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023537 · Cited by 64
Long, Y., & Luo, J. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2998906 · Cited by 80
“We collected drug-drug interactions in recently updated Drug-bank (https://www.drugbank.ca/ releases/latest) [41].”
BackgroundMinimal-uncertainty prediction of general drug-likeness based on Bayesian neural networks
Beker, W., Wołos, A., Szymkuć, S., & Grzybowski, B. A. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0209-y · Cited by 58
Tejera, E., Munteanu, C. R., López‐Cortés, A., Cabrera‐Andrade, A., & Pérez‐Castillo, Y. (2020) · Molecules · doi:10.3390/molecules25215172 · Cited by 64
“The QSAR model constructed for the inhibitors of the Mpro protease of SARS-CoV was used as the first stage in virtual screening of DrugBank molecules [53].”
MethodJarada, T. N., Rokne, J. G., & Alhajj, R. (2021) · BMC Bioinformatics · doi:10.1186/s12859-020-03950-3 · Cited by 70
Metadata
- Authors
- Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., Knox, C., & Wilson, M.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Wishart, David S
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-08
- Volume
- 46
- Issue
- D1
- Pages
- D1074-D1082
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5753335
- OpenAlex
- W2767891136
- Cited by
- 8,404
- References
- 22
- Citations by year
- 2026: 617 · 2025: 929 · 2024: 1327 · 2023: 1363 · 2022: 1322 · 2021: 1175 · 2020: 957 · 2019: 502 · 2018: 201 · 2017: 5
- FWCI
- 343.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Genome Alberta
- Health Canada
- Canadian Institutes of Health Research
- National Human Genome Research Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- DrugBank, drug databases, drug-drug interactions, food-drug interactions, therapeutic target, drug mechanisms, drug indications, pharmacometabolomics, pharmacoproteomics, drug repurposing, clinical trials, investigational drugs
- MeSH terms
- Drug Interactions, User-Computer Interface, Food-Drug Interactions, Polymorphism, Single Nucleotide, Metabolome, Transcriptome, Databases, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

